Tag:
Howard Solomon
Latest Headlines
Latest Headlines
Forest lambastes Icahn in proxy-fight letter
Forest Laboratories ( $FRX ) got up on its soapbox today in an electioneering letter to shareholders. In the midst of a proxy fight with Carl Icahn & Co., Forest pleaded with shareholders to vote
Forest taps lobbyist to aid Solomon at HHS
Forest Laboratories is stepping up its fight on behalf of CEO Howard Solomon. In the face of threats that Solomon would be barred from doing business with the federal government, the company has
Forest proxy battle heats up as meeting nears
Aiming to thwart activist investor Carl Icahn ( photo ), Forest Laboratories ( $FRX ) plans to expand its board and bring in three new members. Two current board members--William Candee, who's served
Icahn sues Forest for info on Solomon's woes
Carl Icahn's ( photo ) proxy-fight tactics for Forest Laboratories are growing clearer. High River, an Icahn investment firm, has sued Forest for information on CEO Howard Solomon's battle with the
Forest fights back against Icahn in filing
Forest Laboratories CEO Howard Solomon took aim at Carl Icahn in an SEC filing this week after the activist investor made critical comments about the company's management and recent performance. Last
Forest shareholder demands CEO's resignation
More pressure on Forest Laboratories CEO Howard Solomon. In response to a move to exclude Solomon from doing business with the federal government, shareholder AFL-CIO is calling for the CEO's head,
Feds target Forest again with Justice subpoena
Forest Laboratories says it has received a subpoena from the Justice Department seeking documents related to three of its blood pressure drugs, including Benicar and Azor. No details yet about the
HHS move to bar Solomon raises pharma fears
The U.S. government's move against Forest Laboratories CEO Howard Solomon has set the pharma industry abuzz. After all, barring Solomon from the drug business is a step outside the enforcement box.
